Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

DIABETIC MACULAR EDEMA.

Ovidiu Musat, Corina Cernat, Mahdi Labib

Romanian Journal of Ophthalmology

|March 17, 2016

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transmission Electron Microscopy Corneal Ultrastructure Study in Hematocornea of Corneal Transplant Graft.

Diagnostics (Basel, Switzerland)·2026

Same author

High-Order Aberrations in Cataract Surgery: Current Status and Future Perspectives: A Scoping Review.

Medicina (Kaunas, Lithuania)·2026

Same author

Surgical Management of Complicated Chronic Uveitis: A Case Report.

Romanian journal of ophthalmology·2025

Same author

A Case Series of Serious Adverse Events Following Anti-VEGF Intravitreal Injections.

Romanian journal of ophthalmology·2025

Same author

Promoting Re-Epithelialization in Diabetic Foot Wounds Using Integrative Therapeutic Approaches.

Bioengineering (Basel, Switzerland)·2025

Same author

"An Unusual Case of Bilateral Sudden Mixed Hearing Loss with Complete Remission": A Case Report and Pathophysiological Considerations.

Reports (MDPI)·2025

Same journal

Neurofibromatosis Type 1 with Plexiform Neurofibroma: A Novel Mutation Uncovered.

Romanian journal of ophthalmology·2026

Same journal

Isolated Third Nerve Palsy and Alternate Hemiparesis in Brain Stem Stroke: A Case Report.

Romanian journal of ophthalmology·2026

Same journal

Innovations in Corneal Transplantation: The Role of Eye Banks, Donor Corneas, and Artificial Alternatives in Combating Worldwide Corneal Blindness.

Romanian journal of ophthalmology·2026

Same journal

Neural Network - Supported Prognostic Assessment of Apoptotic and Inflammatory Markers in Neovascular Glaucoma.

Romanian journal of ophthalmology·2026

Same journal

Visual Improvement and Optical Quality Changes After Keratoplasty in Macular Corneal Dystrophy in Romania.

Romanian journal of ophthalmology·2026

Same journal

Fat Infiltration in Eyelids: An Uncommon Clinical Case with Long-Term Monitoring.

Romanian journal of ophthalmology·2026

See all related articles

Diabetic macular edema (DME) is a leading cause of vision loss. Current treatments include laser photocoagulation, intraocular steroids, anti-VEGF, and PKCβ inhibitors, with optical coherence tomography (OCT) aiding monitoring.

Area of Science:

Ophthalmology
Endocrinology
Medical Retina

Background:

Diabetic macular edema (DME) is the primary cause of vision impairment in diabetic individuals.
Pathophysiological understanding drives interest in novel pharmacologic therapies for DME.
Established treatments include laser photocoagulation, intraocular steroids, anti-vascular endothelial growth factor (VEGF) agents, and protein kinase C-beta (PKCβ) inhibitors.

Purpose of the Study:

To review current understanding and treatment strategies for diabetic macular edema.
To highlight the role of emerging pharmacologic therapies alongside standard care.
To emphasize the utility of optical coherence tomography (OCT) in DME management.

Main Methods:

Literature review of pathophysiology and treatment modalities for DME.

More Related Videos

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Mar 24, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression

Published on: January 12, 2024

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Analysis of current clinical guidelines, including Early Treatment of Diabetic Retinopathy Study (ETDRS).

Discussion of pharmacologic agents: intraocular steroids, anti-VEGF, and PKCβ inhibitors.

Main Results:

Laser photocoagulation remains a standard care treatment for DME.
Pharmacologic therapies (steroids, anti-VEGF, PKCβ inhibitors) show potential benefits.
Optical coherence tomography (OCT) is crucial for monitoring DME progression and treatment response.

Conclusions:

Effective management of diabetic macular edema requires a multi-faceted approach.
Ongoing research into pharmacologic treatments offers promising alternatives and adjuncts.
OCT imaging is indispensable for personalized DME treatment strategies.